The effect of curcumin on human B-cell immortalization by Epstein-Barr virus

被引:0
|
作者
Ranjan, D [1 ]
Siquijor, A [1 ]
Johnston, TD [1 ]
Wu, GH [1 ]
Nagabhuskahn, M [1 ]
机构
[1] Univ Kentucky, Dept Surg, Transplantat Sect, Lexington, KY USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cyclosporine is a commonly used immunosuppressant in solid-organ transplantation. It is, however, associated with an increased incidence of Epstein-Barr virus (EBV)induced post-transplant lymphoproliferative disorder (PTLD). In this study, human B lymphocytes isolated from healthy volunteers were immortalized in vitro with EBV. The effect of oxidative stress mediated by cyclosporine A or hydrogen peroxide on in vitro B cell immortalization was studied by coculturing immortalized B cells with cyclosporine A and hydrogen peroxide. Curcumin, a phenolic extract of the spice turmeric, was then used to observe its effect on this process. We found that in vitro B-cell immortalization with EBV was promoted by the oxidative stress induced by cyclosporine A and hydrogen peroxide, with the maximum effect seen at concentrations of 500 ng/ml and 100 mu M, respectively. Curcumin blocked the B-cell immortalization in a dose-dependent fashion with nearly complete inhibition at 20 mu M. We conclude that, because both hydrogen peroxide and cyclosporine A strongly promote in vitro B-cell immortalization with EBV (the putative process responsible for PTLD) and curcumin, an extract of a common spice is an effective inhibitor of this process; curcumin may be an effective adjunct in the prevention of PTLD in the patients undergoing therapy with cyclosporine A.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 50 条
  • [31] Incorrect use of "immortalization" for B-lymphoblastoid cell lines transformed by Epstein-Barr virus
    Sugimoto, M
    Furuichi, Y
    Ide, T
    Goto, M
    JOURNAL OF VIROLOGY, 1999, 73 (11) : 9690 - 9691
  • [32] FUNCTIONAL-ANALYSIS OF AN EPSTEIN-BARR VIRUS-NONTRANSFORMED HUMAN B-CELL LINE
    YASUDA, Y
    IWASAKI, T
    HAMANO, T
    NAGAI, K
    ACTA HAEMATOLOGICA, 1988, 80 (03) : 139 - 144
  • [33] NEGATIVE MODULATION OF EPSTEIN-BARR VIRUS EPISOMES BY A HUMAN B-CELL GROWTH-FACTOR
    MORGAN, J
    ROOME, A
    MAIZEL, A
    SHARMA, S
    JOURNAL OF VIROLOGY, 1989, 63 (07) : 3190 - 3194
  • [34] B-CELL CHARACTERISTICS OF HUMAN PERIPHERAL AND CORD BLOOD LYMPHOCYTES TRANSFORMED BY EPSTEIN-BARR VIRUS
    PATTENGALE, PK
    SMITH, RW
    GERBER, P
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (04): : 1081 - 1086
  • [35] B-CELL CHARACTERISTICS OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES TRANSFORMED BY EPSTEIN-BARR VIRUS
    PATTENGALE, PK
    SMITH, RW
    GERBER, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 71 - 71
  • [36] Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization
    A Y Hafez
    J E Messinger
    K McFadden
    G Fenyofalvi
    C N Shepard
    G M Lenzi
    B Kim
    M A Luftig
    Oncogenesis, 2017, 6 : e349 - e349
  • [37] Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus
    Linnstaedt, Sarah D.
    Gottwein, Eva
    Skalsky, Rebecca L.
    Luftig, Micah A.
    Cullen, Bryan R.
    JOURNAL OF VIROLOGY, 2010, 84 (22) : 11670 - 11678
  • [38] Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines
    Beatty, PR
    Krams, SM
    Esquivel, CO
    Martinez, OM
    TRANSPLANTATION, 1998, 65 (09) : 1248 - 1255
  • [39] Role of Epstein-Barr virus infection in polyclonal binucleated B-cell lymphocytosis
    Jaubert, D
    deJaureguiberry, JP
    Marlier, S
    PRESSE MEDICALE, 1997, 26 (32): : 1531 - 1531
  • [40] Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma
    Liu, Fang
    Tian, Sufang
    Liu, Qing
    Deng, Yuanfei
    He, Qingyan
    Shi, Qianyun
    Chen, Gang
    Xu, Xiuli
    Yuan, Jiayin
    Nakamura, Shigeo
    Karube, Kennosuke
    Wang, Zhe
    CANCER MEDICINE, 2024, 13 (04):